54
Growth Score in past quarter
pts
Heat Score 54 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1730211
Marrek personalize the management of cardiac arrhythmia disease through advancing technologies for clinical assessment and evaluation.
- Nathan Burgon: Innovation Vice President & Services
- Nassir Marrouche: Founder
About the Company
Marrek is the most prevalent type of cardiac arrhythmia (abnormal heart rhythm). It damages the tissue in the left atrium of the heart over time. AFib raises the likelihood of a stroke or heart failure. Doctors currently have a percent chance of success treating AFib in their patients using current ablation procedures (ablation is an AFib treatment
designed to eliminate electrical signals that trigger abnormal heart rhythms).